Can international standards in ovarian cancer treatment be attained by low- and middle-income countries?

Ovarian cancer is the third most deadly cancer in females from low- and middle-income countries after breast and cervical cancer. Late diagnosis is a contributing factor, as serous high grade carcinomas are mostly diagnosed in advanced stages (stage III 51%, stage IV 29%), affecting overall and